<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>2020 AACR online Day 1 | Just for your understanding</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <script data-ad-client="ca-pub-6993071793241884" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  </head>

  <body>
    <nav>
    <ul class="menu">
      
      <li><a href="/">Home</a></li>
      
      <li><a href="/about/">About</a></li>
      
      <li><a href="/categories/">Categories</a></li>
      
      <li><a href="/tags/">Tags</a></li>
      
      <li><a href="/index.xml">Subscribe</a></li>
      
    </ul>
    <hr/>
    </nav>

<div class="article-meta">
<h1><span class="title">2020 AACR online Day 1</span></h1>
<h2 class="author">Zijian</h2>
<h2 class="date">2020/04/27</h2>
</div>

<main>
<h1 id="1-continuous-vs-intermittent-dosing">1. Continuous vs Intermittent dosing</h1>
<blockquote>
<p>The title is &ldquo;SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma&rdquo;.</p>
</blockquote>
<blockquote>
<p>There are several tantalizing preclinical examples to support intermittent or pulsatile therapy but little clinical evidence</p>
</blockquote>
<blockquote>
<p>pusatile therapy: another form of intermittent therapy</p>
</blockquote>
<h1 id="2-combination-of-io-plus-targeted-therapy">2. Combination of IO plus targeted therapy</h1>
<blockquote>
<p>Clearly works in certain contexts (e.g. meloanoma, kidney cancer) but we don&rsquo;t know why.</p>
</blockquote>
<h1 id="3-cancer-cell-signaling-networks">3. Cancer cell signaling networks</h1>
<blockquote>
<p>Oncogene addication</p>
<ul>
<li>Targeted therapies</li>
<li>Signaling rewiring</li>
<li>Resistance</li>
</ul>
</blockquote>
<h1 id="4-phenomics">4. Phenomics</h1>
<blockquote>
<p>Tumor types, Histology, Demographics, vital status, detailed clinicopathology, prior Rx, outcomes</p>
</blockquote>

</main>

  <footer>
  <script src="//yihui.name/js/math-code.js"></script>
<script async src="//cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML"></script>

<script async src="//yihui.name/js/center-img.js"></script>

  
  <hr/>
  Â© <a href="https://zijzhang.netlify.com">Zijian Zhang</a> 2018 &ndash; 2019 | <a href="https://github.com/zijzhang">Github</a>
  
  </footer>
  </body>
</html>

